Filter announcements
Loading...
Incorporated in 1980, Valiant Laboratories Limited is a pharmaceutical ingredient manufacturing company in India having focuses on manufacturing Paracetamol.
Valiant Laboratories Limited has informed the Exchange regarding Dispatch of Annual Report for FY 2025-26 and Notice of 5th Annual General Meeting to the members of the Company.
Valiant Laboratories' bank loan facilities worth INR 56 Cr have been assigned a new credit rating of IND BBB/Stable by India Ratings and Research (Ind-Ra). The short-term facilities received an IND A2 rating. This initial rating provides investors with a view on the company's creditworthiness and financial health.
Valiant Labs will hold its 5th Annual General Meeting via VC/OAVM. Shareholders can access the Annual Report for FY2025-26 and AGM Notice through the company website's web-link. Update your email with RTA/DP for direct future communications.
Valiant Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026 and the Annual Report for the FY 2025-26
Valiant Laboratories Limited has informed the Exchange about Copy of Newspaper Publication w.r.t. 5th AGM of the Company